Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Mar 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4970507013 | Product containing alogliptin and pioglitazone (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4970508015 | Alogliptin- and pioglitazone-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing alogliptin and pioglitazone (medicinal product) | Is a | Product containing pioglitazone | true | Inferred relationship | Existential restriction modifier | ||
| Product containing alogliptin and pioglitazone (medicinal product) | Is a | Product containing alogliptin | true | Inferred relationship | Existential restriction modifier | ||
| Product containing alogliptin and pioglitazone (medicinal product) | Has active ingredient | Pioglitazone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing alogliptin and pioglitazone (medicinal product) | Has active ingredient | Alogliptin | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only alogliptin and pioglitazone (medicinal product) | Is a | True | Product containing alogliptin and pioglitazone (medicinal product) | Inferred relationship | Existential restriction modifier | |
| Product containing alogliptin and pioglitazone in oral dose form (medicinal product form) | Is a | True | Product containing alogliptin and pioglitazone (medicinal product) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR